Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study [Phase 3]
Phase 3 study results examining how retigabine (ezogabine) affects cortical excitability as measured by transcranial magnetic stimulation in…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities [Phase 3]
Phase 3 clinical trial evaluating melatonin to improve sleep in children with epilepsy and neurodevelopmental disabilities has completed.
-
FDA approval · 2014-12-01FDA Approved: TOPIRAMATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA granted approval of a supplemental application for Topiramate filed by Unichem Pharmaceuticals (USA), Inc., under an ANDA.
-
FDA approval · 2014-12-01FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Topiramate from Glenmark Pharmaceuticals, authorizing an update or expansion of its labeling/app…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin [Phase 1]
Phase 1 trial assessing the effect of BIA 2-093 on the steady-state pharmacodynamic and pharmacokinetic profiles of warfarin, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam [Phase 3]
Phase 3 trial evaluating the efficacy and tolerability of adding lacosamide (Vimpat) to levetiracetam in epilepsy has completed with results…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Cerebral Metabolic Changes Associated With Thalamic Stimulation [Phase 3]
This clinical trial update notes cerebral metabolic changes associated with thalamic stimulation in a Phase 3 study for epilepsy. The trial …
-
FDA approval · 2014-11-20FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2014-11-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Ltd)
FDA approved a supplemental application for divalproex sodium from Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2014-11-20FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for DEPAKOTE ER (divalproex sodium) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution
This document reports the completion and posting of results for an observational study of infants prescribed Keppra (levetiracetam) oral sol…
-
FDA approval · 2014-11-18FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Topiramate submitted by Zydus Lifesciences Limited.
-
FDA label_change · 2014-11-08FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Sun Pharmaceutical Industries to update the product labeling.
-
FDA approval · 2014-11-08FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for gabapentin (generic anticonvulsant) under the approved ANDA.
-
FDA approval · 2014-11-08FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin submitted by Ascend Laboratories, LLC (ANDA 090858).
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. [Phase 1]
Open-label Phase 1 study evaluating drug interaction between eslicarbazepine acetate and lamotrigine in epilepsy; study completed.
-
FDA approval · 2014-11-04FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for levetiracetam submitted by Torrent Pharmaceuticals Limited. This action extends the regulato…
-
FDA approval · 2014-11-03FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, updating the regulatory status for this generic pro…
-
FDA approval · 2014-10-23FDA Approved: GABAPENTIN — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for gabapentin filed by Quallent Pharmaceuticals Health LLC under ANDA200651, enabling marketing of …
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating enteral levetiracetam for seizure control in pediatric cerebral malaria has completed with results poste…
-
CLINICAL_TRIALS research · 2014-10-16Clinical Trial Update: PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1
PuLsE 2 is an observational long-term follow-up study of PuLsE 1 in epilepsy. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy [Phase 3]
Phase 3 open-label study assessing levetiracetam monotherapy in patients with newly diagnosed focal epilepsy.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: REMS Retigabine Study
A REMS-related clinical trial update for retigabine (ezogabine) in epilepsy has completed. The study was sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS safety_alert · 2014-10-01Clinical Trial Update: Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)
Clinical trial update noting birth defects associated with exposure to lamotrigine during pregnancy based on EUROCAT data.
-
FDA approval · 2014-09-26FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the gener…